Can Waves of Autoimmune Diseases Occur after the COVID-19 Pandemic?


Cite item

Full Text

About the authors

SeyedAhmad SeyedAlinaghi

Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences

Email: info@benthamscience.net

Pegah Mirzapour

Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences

Email: info@benthamscience.net

Esmaeil Mehraeen

Department of Health Information Technology, Khalkhal University of Medical sciences

Author for correspondence.
Email: info@benthamscience.net

References

  1. SeyedAlinaghi S, Karimi A, Barzegary A, et al. Mucormycosis infection in patients with COVID-19: A systematic review. Health Sci Rep. 2022; 5(2): e529. doi: 10.1002/hsr2.529.
  2. Mehraeen E, Dadras O, Afsahi AM, et al. Vaccines for COVID-19: A systematic review of feasibility and effectiveness. Infect Disord Drug Targets 2022; 22(2): e230921196758. doi: 10.2174/1871526521666210923144837 PMID: 34554905
  3. Qian SZ, Hong W. Lingjie-mao, Chenfeng-lin, Zhendong-fang, Pan JY. Clinical characteristics and outcomes of severe and critical patients with 2019 novel coronavirus disease (COVID-19) in Wenzhou: A retrospective study. Front Med (Lausanne) 2020; 7: 552002. doi: 10.3389/fmed.2020.552002 PMID: 33015108
  4. Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells 2021; 10(12): 3592. doi: 10.3390/cells10123592 PMID: 34944099
  5. Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol 2021; 33(2): 155-62. doi: 10.1097/BOR.0000000000000776 PMID: 33332890
  6. Jiang J, Zhao M, Chang C, Wu H, Lu Q. Type I interferons in the pathogenesis and treatment of autoimmune diseases. Clin Rev Allergy Immunol 2020; 59(2): 248-72. doi: 10.1007/s12016-020-08798-2 PMID: 32557263
  7. Bakshi J, Segura BT, Wincup C, Rahman A. Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus. Clin Rev Allergy Immunol 2018; 55(3): 352-67. doi: 10.1007/s12016-017-8640-5 PMID: 28853005
  8. Cheung TT, McInnes IB, Eds. Future therapeutic targets in rheumatoid arthritis? Seminars in immunopathology. Springer 2017.
  9. Davis LS, Reimold AM. Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus. Rheumatology 2017; 56 (Suppl. 1): i100-13. doi: 10.1093/rheumatology/kew417 PMID: 28375452
  10. Mavragani CP, Moutsopoulos HM. Sjِöِgren’s syndrome: Old and new therapeutic targets. J Autoimmun 2020; 110: 102364. doi: 10.1016/j.jaut.2019.102364 PMID: 31831255
  11. Seibel MJ, Cooper MS, Zhou H. Glucocorticoid-induced osteoporosis: Mechanisms, management, and future perspectives. Lancet Diabetes Endocrinol 2013; 1(1): 59-70. doi: 10.1016/S2213-8587(13)70045-7 PMID: 24622268
  12. Hussein HM, Rahal EA. The role of viral infections in the development of autoimmune diseases. Crit Rev Microbiol 2019; 45(4): 394-412. doi: 10.1080/1040841X.2019.1614904 PMID: 31145640
  13. Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms. Viruses 2019; 11(8): 762. doi: 10.3390/v11080762 PMID: 31430946
  14. Winchester NE, Calabrese C, Calabrese L. The intersection of COVID-19 and autoimmunity: What is our current understanding? Pathog Immun 2021; 6(1): 31-54. doi: 10.20411/pai.v6i1.417 PMID: 33969248
  15. Ramos-Casals M. Brito-Zerَón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021; 17(6): 315-32. doi: 10.1038/s41584-021-00608-z PMID: 33903743
  16. Zacharias H, Dubey S, Koduri G, D’Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev 2021; 20(9): 102883. doi: 10.1016/j.autrev.2021.102883 PMID: 34237419
  17. Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific immune response and the pathogenesis of COVID-19. Int J Mol Sci 2022; 23(3): 1716. doi: 10.3390/ijms23031716 PMID: 35163638
  18. Hammoudeh SM, Hammoudeh AM, Bhamidimarri PM, et al. Systems immunology analysis reveals the contribution of pulmonary and extrapulmonary tissues to the immunopathogenesis of severe COVID-19 patients. Front Immunol 2021; 12: 595150. doi: 10.3389/fimmu.2021.595150 PMID: 34262555
  19. Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: A systematic review and meta-analysis. Rev Med Virol 2020; 30(6): 1-9. doi: 10.1002/rmv.2141 PMID: 32845568
  20. Sacchi MC, Tamiazzo S, Stobbione P, et al. SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 2021; 14(3): 898-907. doi: 10.1111/cts.12953 PMID: 33306235

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers